Presentation Switching ACS Patients from Prasugrel to Clopidogrel Presenter: M. Kerneis February 21, 2013 REGISTER for free or LOG IN to view this content CAD Pharma Factoid Up Next Presentation ACC 2013 Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL) Presenter: David R. Holmes March 08, 2013 More slides + Presentation RESPECT: Closure of Patent Foramen Ovale (PFO) vs. Medical Therapy After Cryptogenic Stroke Presenter: John D. Carroll March 20, 2013 Presentation FFR-Guided Revascularization: Implications of a Diagnostic ‘Gray Zone’ and Measurement Variability on Clinical Decisions Presenter: Ricardo Petraco March 22, 2013 We Recommend
Presentation ACC 2013 Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL) Presenter: David R. Holmes March 08, 2013
Presentation RESPECT: Closure of Patent Foramen Ovale (PFO) vs. Medical Therapy After Cryptogenic Stroke Presenter: John D. Carroll March 20, 2013
Presentation FFR-Guided Revascularization: Implications of a Diagnostic ‘Gray Zone’ and Measurement Variability on Clinical Decisions Presenter: Ricardo Petraco March 22, 2013